Disparities in prescribing of sodium-glucose co-transporter-2 (SGLT2) inhibitors and DPP-4 inhibitors in people with Type 2 diabetes and chronic kidney disease (CKD)
Main Authors: | , , , , , , |
---|---|
格式: | Conference item |
語言: | English |
出版: |
Wiley
2018
|